Lv11
40 积分 2024-06-02 加入
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
6小时前
待确认
Characterization of Novel Mouse Esophageal Squamous Cell Carcinoma Cell Lines and Their Utility as Preclinical Models
1年前
已完结
皖公网安备34019202002308
